Hepatitis B and C virus infection as a risk factor for Parkinson's disease in Israel-A nationwide cohort study
Related Experiment Video
Updated: Oct 23, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Lilach Goldstein1, Haya Fogel-Grinvald2, Israel Steiner1
1Department of Neurology, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Insights
This study found a minor increased risk of Parkinson's disease (PD) in patients with hepatitis C virus (HCV) infection. Liver disease, rather than viral infection, may be a risk factor for PD.
Area of Science:
- Neurology
- Hepatology
- Epidemiology
Background:
- Hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are significant global health concerns.
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- The potential association between viral hepatitis and PD requires further investigation.
Purpose of the Study:
- To investigate the association between HCV, HBV, and PD in Israel.
- To compare the prevalence of PD in patients with HCV, HBV, and nonalcoholic steatohepatitis (NASH) against a reference cohort.
Main Methods:
- A retrospective cohort study utilizing the Clalit Healthcare Service database in Israel.
- Construction of cohorts for HCV, HBV, and NASH patients.
- Comparison of PD prevalence between these cohorts and a general reference population.
Main Results:
- The overall prevalence of PD in Israel was 0.5%.
- HCV-positive patients showed a slightly increased odds ratio (OR) for PD (1.18, 95% CI: 1.04-1.35).
- Hepatitis B virus (HBV) and co-infection with HCV and HBV did not show a significant association with increased PD risk.
Conclusions:
- HCV infection is associated with a minor increased risk of PD.
- Nonalcoholic steatohepatitis (NASH) also showed an increased risk for PD, suggesting liver disease itself might be a risk factor.
- The findings indicate a potential link between liver disease and PD, possibly due to cirrhosis-induced parkinsonism misclassified as PD.
Objective:
To study the association between hepatitis C and B viruses and Parkinson's disease (PD) in Israel.
Methods:
A retrospective cohort study was performed by analyzing the computerized database of Clalit Healthcare Service in Israel. Cohorts of people with hepatitis C virus (HCV) infection, hepatitis B virus (HBV) infection and nonalcoholic steatohepatitis (NASH) were constructed and compared to a reference cohort for prevalence of PD.
Results:
The prevalence of PD in Israel was found to be 0.5% in the general population. The M-H (Mantel-Haenszel) odds ratio (OR) of PD for HBV-positive patients was 1.08 (95% CI: 1.00-1.16). The M-H OR of PD for HCV-positive patients was 1.18 (95% CI: 1.04-1.35). The M-H OR of PD for patients infected with both hepatitis C and B was 1.13 (95% CI: 0.87-1.47). The M-H OR of PD for patients diagnosed with nonalcoholic steatohepatitis (NASH) was 1.13 (95% CI: 1.08-1.19).
Conclusions:
We report evidence supporting a minor increased risk for PD in patients with HCV. Co infection of HCV and HBV was not associated with an increased risk for PD. The increased risk for PD in the group of patients with NASH, raises the possibility that liver disease per se is a risk factor for PD rather than viral infection. In addition, it cannot be ruled out that the association is, at least in part, the result of the occurrence of cirrhosis induced parkinsonism that was misclassified as PD.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Hepatitis
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Viral Hepatitis I: Introduction

